Skip to content
OpenCapital
Get started

Rogers Corporation ROG EBITDA

EBITDA at other companies

Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$83.58M-35.1%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$46.24M+73.2%
Chemours logo
ChemoursCC
$126M-18.2%
3M logo
3MMMM
——
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
——
Entegris logo
EntegrisENTG
——

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0×0.0×
Current ratio4×+0.1×

Where this comes from

Calculated from Rogers Corporation’s reported figures.

$10.7Mebit+
$13.4MDepreciation Depletion & Amortization
=$24.1M

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's EBITDA?
Rogers Corporation (ROG) reported EBITDA of $24.1M in Q1 2026.
How has Rogers Corporation's EBITDA changed year-over-year?
Rogers Corporation's EBITDA increased by 95.9% year-over-year, from $12.3M to $24.1M.
What is the long-term trend for Rogers Corporation's EBITDA?
Over 3 years (2021 to 2024), Rogers Corporation's EBITDA has grown at a -18.5% compound annual growth rate (CAGR), from $160.5M to $87M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.